Tapewire

Nasdaq · USD

TXMD

TherapeuticsMD, Inc.

Export transactions ↓
Tapewire entity
7541
SEC CIK
0000025743
Parsed reports
242

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202510
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 14, 2021 Filed May 18, 2021 10:55 UTC PurchaseCommon Stock 5,000 $1.06 $5,300.00
Disclosure

SEC source: 0001387131-21-005770 · ownership.xml · nonDerivative · entry 1

Thompson Tommy G · CIK 0001324863 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 704,600

F1 · price: The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions with prices ranging from $1.055 to $1.06 for an average weighted sale price of $1.06. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The reported securities are owned by Thompson Family Investments, LLC, an entity solely owned by Thompson Family Holdings, LLC, an entity solely owned by Mr. Thompson.

Read SEC document
May 11, 2021 Filed May 13, 2021 00:44 UTC
Donegan Michael CCAO and VP Finance
SaleCommon Stock 4,842 $1.04 $5,035.68
Disclosure

SEC source: 0001387131-21-005571 · ownership.xml · nonDerivative · entry 2

Donegan Michael C · CIK 0001627810 · CAO and VP Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,158

F2 · kind: The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.

F3 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $1.03 to $1.06 for an average weighted sale price of $1.04. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
May 11, 2021 Filed May 13, 2021 00:43 UTC
Walker Marlan DGeneral Counsel
SaleCommon Stock 21,592 $1.04 $22,455.68
Disclosure

SEC source: 0001387131-21-005570 · ownership.xml · nonDerivative · entry 2

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,908

F2 · kind: The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.

F3 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $1.03 to $1.06 for an average weighted sale price of $1.04. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
May 11, 2021 Filed May 13, 2021 00:39 UTC
BORKOWSKI EDWARDEVP, Operations
SaleCommon Stock 44,252 $1.04 $46,022.08
Disclosure

SEC source: 0001387131-21-005568 · ownership.xml · nonDerivative · entry 2

BORKOWSKI EDWARD · CIK 0001197542 · EVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,248

F2 · kind: The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.

Read SEC document
May 11, 2021 Filed May 13, 2021 00:38 UTC
Milligan John C.K. IVSecretary/CEO of subsidiary
SaleCommon Stock 44,252 $1.04 $46,022.08
Disclosure

SEC source: 0001387131-21-005567 · ownership.xml · nonDerivative · entry 2

Milligan John C.K. IV · CIK 0001532230 · Secretary/CEO of subsidiary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,752,703

F2 · kind: The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.

Read SEC document
May 11, 2021 Filed May 13, 2021 00:36 UTC
Finizio Robert GDirector · CEO
SaleCommon Stock 67,697 $1.04 $70,404.88
Disclosure

SEC source: 0001387131-21-005565 · ownership.xml · nonDerivative · entry 2

Finizio Robert G · CIK 0001532235 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,991,637

F2 · kind: The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.

Read SEC document
May 10, 2021 Filed May 13, 2021 00:44 UTC
Donegan Michael CCAO and VP Finance
Exercise / conversionRestricted Stock Units · Derivative 19,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-21-005571 · ownership.xml · derivative · entry 3

Donegan Michael C · CIK 0001627810 · CAO and VP Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,000

Underlying: Common Stock · 19,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 10, 2021, the reporting person received 19,000 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021.

F4 · shares: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.

F5 · derivative.exercise_date: The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.

F5 · derivative.expiration_date: The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.

F4 · balance_after: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.

Read SEC document
May 10, 2021 Filed May 13, 2021 00:44 UTC
Donegan Michael CCAO and VP Finance
Exercise / conversionCommon Stock 19,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001387131-21-005571 · ownership.xml · nonDerivative · entry 1

Donegan Michael C · CIK 0001627810 · CAO and VP Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On May 10, 2021, the reporting person received 19,000 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021.

Read SEC document
May 10, 2021 Filed May 13, 2021 00:43 UTC
Walker Marlan DGeneral Counsel
Exercise / conversionRestricted Stock Units · Derivative 50,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-21-005570 · ownership.xml · derivative · entry 3

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,000

Underlying: Common Stock · 50,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 10, 2021, the reporting person received 50,500 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021.

F4 · shares: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.

F5 · derivative.exercise_date: The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.

F5 · derivative.expiration_date: The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.

F4 · balance_after: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.

Read SEC document
May 10, 2021 Filed May 13, 2021 00:43 UTC
Walker Marlan DGeneral Counsel
Exercise / conversionCommon Stock 50,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001387131-21-005570 · ownership.xml · nonDerivative · entry 1

Walker Marlan D · CIK 0001820187 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On May 10, 2021, the reporting person received 50,500 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021.

Read SEC document
May 10, 2021 Filed May 13, 2021 00:39 UTC
BORKOWSKI EDWARDEVP, Operations
Exercise / conversionRestricted Stock Units · Derivative 103,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-21-005568 · ownership.xml · derivative · entry 3

BORKOWSKI EDWARD · CIK 0001197542 · EVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,000

Underlying: Common Stock · 103,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 10, 2021, the reporting person received 103,500 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021.

F3 · shares: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.

F4 · derivative.exercise_date: The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.

F4 · derivative.expiration_date: The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.

F3 · balance_after: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.

Read SEC document
May 10, 2021 Filed May 13, 2021 00:39 UTC
BORKOWSKI EDWARDEVP, Operations
Exercise / conversionCommon Stock 103,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001387131-21-005568 · ownership.xml · nonDerivative · entry 1

BORKOWSKI EDWARD · CIK 0001197542 · EVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On May 10, 2021, the reporting person received 103,500 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021.

Read SEC document
May 10, 2021 Filed May 13, 2021 00:38 UTC
Milligan John C.K. IVSecretary/CEO of subsidiary
Exercise / conversionRestricted Stock Units · Derivative 103,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-21-005567 · ownership.xml · derivative · entry 4

Milligan John C.K. IV · CIK 0001532230 · Secretary/CEO of subsidiary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,000

Underlying: Common Stock · 103,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 10, 2021, the reporting person received 103,500 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021.

F4 · shares: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.

F5 · derivative.exercise_date: The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.

F5 · derivative.expiration_date: The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.

F4 · balance_after: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.

Read SEC document
May 10, 2021 Filed May 13, 2021 00:38 UTC
Milligan John C.K. IVSecretary/CEO of subsidiary
Exercise / conversionCommon Stock 103,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001387131-21-005567 · ownership.xml · nonDerivative · entry 1

Milligan John C.K. IV · CIK 0001532230 · Secretary/CEO of subsidiary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,796,955

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On May 10, 2021, the reporting person received 103,500 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021.

Read SEC document
May 10, 2021 Filed May 13, 2021 00:36 UTC
Finizio Robert GDirector · CEO
Exercise / conversionRestricted Stock Units · Derivative 158,334 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-21-005565 · ownership.xml · derivative · entry 4

Finizio Robert G · CIK 0001532235 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 316,666

Underlying: Common Stock · 158,334 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 10, 2021, the reporting person received 158,334 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021.

F4 · shares: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.

F5 · derivative.exercise_date: The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.

F5 · derivative.expiration_date: The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.

F4 · balance_after: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.

Read SEC document
May 10, 2021 Filed May 13, 2021 00:36 UTC
Finizio Robert GDirector · CEO
Exercise / conversionCommon Stock 158,334 Not disclosed Not disclosed
Disclosure

SEC source: 0001387131-21-005565 · ownership.xml · nonDerivative · entry 1

Finizio Robert G · CIK 0001532235 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,059,334

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On May 10, 2021, the reporting person received 158,334 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021.

Read SEC document
March 05, 2021 Filed Mar 9, 2021 02:07 UTC
Finizio Robert GDirector · CEO
GiftCommon Stock 350,000 $0.00 $0.00
Disclosure

SEC source: 0001387131-21-003349 · finizio-form4_030421.xml · nonDerivative · entry 3

Finizio Robert G · CIK 0001532235 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,201,000

Read SEC document
March 04, 2021 Filed Mar 9, 2021 02:07 UTC
Finizio Robert GDirector · CEO
OtherWarrants (right to buy) · Derivative 179,000 $0.00 Strike: $0.24 $0.00
Disclosure

SEC source: 0001387131-21-003349 · finizio-form4_030421.xml · derivative · entry 6

Finizio Robert G · CIK 0001532235 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 179,000 shares

Expires 2021-03-06

F3 · derivative.exercise_date: The warrant vested quarterly in eight equal installments commencing June 30, 2011, becoming fully-vested on March 31, 2013.

Read SEC document
March 04, 2021 Filed Mar 9, 2021 02:07 UTC
Finizio Robert GDirector · CEO
Tax withholdingCommon Stock 29,964 $1.46 $43,747.44
Disclosure

SEC source: 0001387131-21-003349 · finizio-form4_030421.xml · nonDerivative · entry 2

Finizio Robert G · CIK 0001532235 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,551,000

F1 · kind: On March 4, 2021, the reporting person exercised a warrant to purchase 179,000 shares of issuer common stock for $0.2444 per share. The reporting person paid the exercise price on a cashless basis, resulting in the issuer's withholding of 29,964 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 149,036 shares.

Read SEC document
March 04, 2021 Filed Mar 9, 2021 02:07 UTC
Finizio Robert GDirector · CEO
OtherCommon Stock 179,000 $0.24 $43,747.60
Disclosure

SEC source: 0001387131-21-003349 · finizio-form4_030421.xml · nonDerivative · entry 1

Finizio Robert G · CIK 0001532235 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,580,964

Read SEC document
March 04, 2021 Filed Mar 9, 2021 02:06 UTC
Milligan John C.K. IVPresident/Secretary
OtherWarrant (right to buy) · Derivative 179,000 $0.00 Strike: $0.24 $0.00
Disclosure

SEC source: 0001387131-21-003348 · milligan-form4_030421.xml · derivative · entry 5

Milligan John C.K. IV · CIK 0001532230 · President/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 179,000 shares

Expires 2021-03-06

F4 · derivative.exercise_date: The warrant vested quarterly in eight equal installments commencing June 30, 2011, becoming fully-vested on March 31, 2013.

Read SEC document
March 04, 2021 Filed Mar 9, 2021 02:06 UTC
Milligan John C.K. IVPresident/Secretary
Tax withholdingCommon Stock 29,964 $1.46 $43,747.44
Disclosure

SEC source: 0001387131-21-003348 · milligan-form4_030421.xml · nonDerivative · entry 2

Milligan John C.K. IV · CIK 0001532230 · President/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,693,455

F1 · kind: On March 4, 2021, the reporting person exercised a warrant to purchase 179,000 shares of issuer common stock for $0.2444 per share. The reporting person paid the exercise price on a cashless basis, resulting in the issuer's withholding of 29,964 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 149,036 shares.

Read SEC document
March 04, 2021 Filed Mar 9, 2021 02:06 UTC
Milligan John C.K. IVPresident/Secretary
OtherCommon Stock 179,000 $0.24 $43,747.60
Disclosure

SEC source: 0001387131-21-003348 · milligan-form4_030421.xml · nonDerivative · entry 1

Milligan John C.K. IV · CIK 0001532230 · President/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,723,419

Read SEC document
November 24, 2020 Filed Nov 27, 2020 22:09 UTC
Donegan Michael CChief Accounting Officer
GrantRestricted Stock Units · Derivative 230,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-20-010309 · ownership.xml · derivative · entry 1

Donegan Michael C · CIK 0001627810 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 230,000

Underlying: Common Stock · 230,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in two equal installments on November 24, 2021 and November 24, 2022.

F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in two equal installments on November 24, 2021 and November 24, 2022.

Read SEC document
November 24, 2020 Filed Nov 27, 2020 22:05 UTC
Milligan John C.K. IVPresident/Secretary
GrantRestricted Stock Units · Derivative 360,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-20-010306 · ownership.xml · derivative · entry 1

Milligan John C.K. IV · CIK 0001532230 · President/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 360,000

Underlying: Common Stock · 360,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in two equal installments on November 24, 2021 and November 24, 2022.

F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in two equal installments on November 24, 2021 and November 24, 2022.

Read SEC document
November 24, 2020 Filed Nov 27, 2020 22:01 UTC
Finizio Robert GDirector · CEO
GrantRestricted Stock Unit · Derivative 1 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-20-010304 · ownership.xml · derivative · entry 1

Finizio Robert G · CIK 0001532235 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1

Underlying: Common Stock · 1 shares

Expires not disclosed

F1 · derivative.exercise_date: The restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSU will vest on November 24, 2022.

F1 · derivative.expiration_date: The restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSU will vest on November 24, 2022.

Read SEC document
June 18, 2020 Filed Jun 19, 2020 21:11 UTC
Bisaro PaulDirector
GrantRestricted Stock Units · Derivative 96,864 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-20-005822 · ownership.xml · derivative · entry 1

BISARO PAUL · CIK 0001237253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,864

Underlying: Common Stock · 96,864 shares

Expires not disclosed

F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021.

F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021.

Read SEC document
June 18, 2020 Filed Jun 19, 2020 21:11 UTC GrantRestricted Stock Units · Derivative 145,296 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-20-005821 · ownership.xml · derivative · entry 1

Thompson Tommy G · CIK 0001324863 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,296

Underlying: Common Stock · 145,296 shares

Expires not disclosed

F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021.

F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021.

Read SEC document
June 18, 2020 Filed Jun 19, 2020 21:10 UTC GrantRestricted Stock Units · Derivative 96,864 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-20-005820 · ownership.xml · derivative · entry 1

Russell Angus C. · CIK 0001534002 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,864

Underlying: Common Stock · 96,864 shares

Expires not disclosed

F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021.

F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021.

Read SEC document
June 18, 2020 Filed Jun 19, 2020 21:10 UTC GrantRestricted Stock Units · Derivative 96,864 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-20-005819 · ownership.xml · derivative · entry 1

Naughton Gail K · CIK 0001297506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,864

Underlying: Common Stock · 96,864 shares

Expires not disclosed

F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021.

F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021.

Read SEC document
June 18, 2020 Filed Jun 19, 2020 21:09 UTC GrantRestricted Stock Units · Derivative 96,864 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-20-005818 · ownership.xml · derivative · entry 1

MUSING JULES A. · CIK 0001524216 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,864

Underlying: Common Stock · 96,864 shares

Expires not disclosed

F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021.

F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021.

Read SEC document
June 18, 2020 Filed Jun 19, 2020 21:08 UTC
Ling KarenDirector
GrantRestricted Stock Units · Derivative 96,864 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-20-005817 · ownership.xml · derivative · entry 1

Ling Karen · CIK 0001597450 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,864

Underlying: Common Stock · 96,864 shares

Expires not disclosed

F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021.

F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021.

Read SEC document
June 18, 2020 Filed Jun 19, 2020 21:08 UTC GrantRestricted Stock Units · Derivative 96,864 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-20-005816 · ownership.xml · derivative · entry 1

Collins Cooper C. · CIK 0001485508 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,864

Underlying: Common Stock · 96,864 shares

Expires not disclosed

F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021.

F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021.

Read SEC document
June 18, 2020 Filed Jun 19, 2020 21:07 UTC GrantRestricted Stock Units · Derivative 96,864 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-20-005815 · ownership.xml · derivative · entry 1

CARROLL J MARTIN · CIK 0001279901 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,864

Underlying: Common Stock · 96,864 shares

Expires not disclosed

F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021.

F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021.

Read SEC document
June 18, 2020 Filed Jun 19, 2020 21:07 UTC
DArecca JamesChief Financial Officer
GrantRestricted Stock Units · Derivative 651,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-20-005814 · ownership.xml · derivative · entry 2

DArecca James · CIK 0001583903 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 651,500

Underlying: Common Stock · 651,500 shares

Expires not disclosed

F2 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning June 1, 2021 (the one-year anniversary of the date of the reporting person's appointment as Chief Financial Officer), becoming fully vested on June 1, 2023.

F2 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning June 1, 2021 (the one-year anniversary of the date of the reporting person's appointment as Chief Financial Officer), becoming fully vested on June 1, 2023.

Read SEC document
June 18, 2020 Filed Jun 19, 2020 21:07 UTC
DArecca JamesChief Financial Officer
GrantPerformance Stock Units · Derivative 151,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-20-005814 · ownership.xml · derivative · entry 1

DArecca James · CIK 0001583903 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,500

Underlying: Common Stock · 151,500 shares

Expires not disclosed

F1 · derivative.exercise_date: The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer.

F1 · derivative.expiration_date: The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
June 18, 2020 Filed Aug 8, 2020 01:16 UTC Amendment
DArecca JamesChief Financial Officer
GrantRestricted Stock Units · Derivative 651,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-20-007227 · darecca-form4a_061820.xml · derivative · entry 2

DArecca James · CIK 0001583903 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 651,500

Underlying: Common Stock · 651,500 shares

Expires not disclosed

F2 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning June 1, 2021 (the one-year anniversary of the date of the reporting person's appointment as Chief Financial Officer), becoming fully vested on June 1, 2023.

F2 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning June 1, 2021 (the one-year anniversary of the date of the reporting person's appointment as Chief Financial Officer), becoming fully vested on June 1, 2023.

Read SEC document
June 18, 2020 Filed Aug 8, 2020 01:16 UTC Amendment
DArecca JamesChief Financial Officer
GrantPerformance Stock Units · Derivative 151,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-20-007227 · darecca-form4a_061820.xml · derivative · entry 1

DArecca James · CIK 0001583903 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,500

Underlying: Common Stock · 151,500 shares

Expires not disclosed

F1 · shares: The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer.

F1 · derivative.exercise_date: The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer.

F1 · derivative.expiration_date: The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer.

F1 · derivative.underlying_shares: The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer.

F1 · balance_after: The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
June 09, 2020 Filed Jun 10, 2020 20:25 UTC PurchaseCommon Stock 47,500 $1.45 $68,875.00
Disclosure

SEC source: 0001387131-20-005591 · ownership.xml · nonDerivative · entry 2

Collins Cooper C. · CIK 0001485508 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,000

Read SEC document
June 09, 2020 Filed Jun 10, 2020 20:06 UTC
Finizio Robert GDirector · CEO
PurchaseCommon Stock 25,000 $1.47 $36,750.00
Disclosure

SEC source: 0001387131-20-005580 · ownership.xml · nonDerivative · entry 2

Finizio Robert G · CIK 0001532235 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,401,964

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.46 to $1.47, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in Footnote (1) to this Form 4.

Read SEC document
June 09, 2020 Filed Jun 10, 2020 20:06 UTC
Finizio Robert GDirector · CEO
PurchaseCommon Stock 21,000 $1.41 $29,610.00
Disclosure

SEC source: 0001387131-20-005580 · ownership.xml · nonDerivative · entry 1

Finizio Robert G · CIK 0001532235 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,376,964

Read SEC document
June 08, 2020 Filed Jun 10, 2020 20:25 UTC PurchaseCommon Stock 26,500 $1.45 $38,425.00
Disclosure

SEC source: 0001387131-20-005591 · ownership.xml · nonDerivative · entry 1

Collins Cooper C. · CIK 0001485508 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,500

Read SEC document
June 05, 2020 Filed Jun 8, 2020 20:07 UTC
Finizio Robert GDirector · CEO
PurchaseCommon Stock 20,000 $1.15 $23,000.00
Disclosure

SEC source: 0001387131-20-005521 · ownership.xml · nonDerivative · entry 2

Finizio Robert G · CIK 0001532235 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,355,964

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.14 to $1.15, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in Footnote (2) to this Form 4.

Read SEC document
June 05, 2020 Filed Jun 8, 2020 20:07 UTC
Finizio Robert GDirector · CEO
PurchaseCommon Stock 10,000 $1.16 $11,600.00
Disclosure

SEC source: 0001387131-20-005521 · ownership.xml · nonDerivative · entry 1

Finizio Robert G · CIK 0001532235 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,335,964

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.16 to $1.17, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in Footnote (1) to this Form 4.

Read SEC document
June 05, 2020 Filed Mar 9, 2021 02:06 UTC
Milligan John C.K. IVPresident/Secretary
GiftCommon Stock 434,814 $0.00 $0.00
Disclosure

SEC source: 0001387131-21-003348 · milligan-form4_030421.xml · nonDerivative · entry 3

Milligan John C.K. IV · CIK 0001532230 · President/Secretary

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

F2 · ownership.nature: Shares were owned by the Milligan Irrevocable Nonexempt Trust - 2014. These securities were held in a trust for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
June 04, 2020 Filed Jun 8, 2020 20:12 UTC PurchaseCommon Stock 8,700 $1.13 $9,831.00
Disclosure

SEC source: 0001387131-20-005525 · ownership.xml · nonDerivative · entry 1

Thompson Tommy G · CIK 0001324863 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 699,600

F1 · ownership.nature: The reported securities are owned by Thompson Family Investments, LLC, an entity solely owned by Thompson Family Holdings, LLC, an entity solely owned by Mr. Thompson.

Read SEC document
June 04, 2020 Filed Jun 8, 2020 20:10 UTC
Bisaro PaulDirector
PurchaseCommon Stock 50,000 $1.14 $57,000.00
Disclosure

SEC source: 0001387131-20-005523 · ownership.xml · nonDerivative · entry 1

BISARO PAUL · CIK 0001237253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Read SEC document
March 30, 2020 Filed Apr 2, 2020 00:33 UTC
Milligan John C.K. IVPresident/Secretary
GrantRestricted Stock Units · Derivative 310,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-20-003593 · milligan-form4_033020.xml · derivative · entry 2

Milligan John C.K. IV · CIK 0001532230 · President/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 310,500

Underlying: Common Stock · 310,500 shares

Expires not disclosed

F2 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.

F2 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.

Read SEC document
March 30, 2020 Filed Apr 2, 2020 00:33 UTC
Milligan John C.K. IVPresident/Secretary
GrantPerformance Stock Units · Derivative 310,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-20-003593 · milligan-form4_033020.xml · derivative · entry 1

Milligan John C.K. IV · CIK 0001532230 · President/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 310,500

Underlying: Common Stock · 310,500 shares

Expires not disclosed

F1 · shares: The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer.

F1 · derivative.exercise_date: The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer.

F1 · derivative.expiration_date: The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer.

F1 · derivative.underlying_shares: The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer.

F1 · balance_after: The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
March 30, 2020 Filed Apr 2, 2020 00:32 UTC
Finizio Robert GDirector · CEO
GrantRestricted Stock Units · Derivative 475,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001387131-20-003592 · finizio-form4_033020.xml · derivative · entry 2

Finizio Robert G · CIK 0001532235 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 475,000

Underlying: Common Stock · 475,000 shares

Expires not disclosed

F2 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.

F2 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.